GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OK Biotech Co Ltd (TPE:4155) » Definitions » Gross-Profit-to-Asset %

OK Biotech Co (TPE:4155) Gross-Profit-to-Asset % : 5.33% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is OK Biotech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. OK Biotech Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was NT$165 Mil. OK Biotech Co's average Total Assets over the quarter that ended in Mar. 2024 was NT$3,091 Mil. Therefore, OK Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 5.33%.


OK Biotech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for OK Biotech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OK Biotech Co Gross-Profit-to-Asset % Chart

OK Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.58 13.72 6.99 11.75 6.43

OK Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.77 8.95 4.37 2.60 5.33

Competitive Comparison of OK Biotech Co's Gross-Profit-to-Asset %

For the Medical Devices subindustry, OK Biotech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OK Biotech Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OK Biotech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where OK Biotech Co's Gross-Profit-to-Asset % falls into.



OK Biotech Co Gross-Profit-to-Asset % Calculation

OK Biotech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=196.884/( (3061.194+3067.358)/ 2 )
=196.884/3064.276
=6.43 %

OK Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=164.708/( (3067.358+3114.957)/ 2 )
=164.708/3091.1575
=5.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


OK Biotech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of OK Biotech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


OK Biotech Co (TPE:4155) Business Description

Traded in Other Exchanges
N/A
Address
No.91, Gongdao 5th Road, Section 2, Hsinchu, TWN, 30070
OK Biotech Co Ltd is engaged in the manufacturing of electronic materials and medical devices. The products of the company include Portable Nebulizer, Blood Glucose Meter, Glucometer, Blood Sugar Meter, Blood Glucose Test Strips, and others.

OK Biotech Co (TPE:4155) Headlines

No Headlines